新型P2Y12受体拮抗剂抗血小板活性的影响因素研究进展(6)
[19] TATARUNAS V,KUPSTYTE N,GIEDRAITIENE A, et al. The impact of CYP2C19*2,CYP4F2*3,and clinical factors on platelet aggregation,CYP4F2 enzyme activity,and 20-hydroxyeicosatetraenoic acid concentration in patients treated with dual antiplatelet therapy[J]. Blood Coagul Fibrinolysis,2017,28(8):658-664.[20] NYLANDER S ......
您现在查看是摘要页,全文长 2736 字符。